Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Yuancheng Gongchuang Technology was a China-based supplier of active pharmaceutical ingredients, pharmaceutical intermediates, steroid and cinnamic-series chemicals, plant extracts, amino acids, vitamins, and related fine chemicals. The company described itself as an integrated R&D, manufacturing, and marketing enterprise serving pharmaceutical, food, beverage, cosmetics, and health-product markets. Available trade-directory profiles indicate operations centered in Wuhan, Hubei, with manufacturing in Xiaogan, and certifications such as ISO 9001 and Kosher reported on commercial listings. The business appears to have been more of a chemical/API and ingredients manufacturer-distributor than a drug-development biotech with a disclosed therapeutic pipeline. Chinese company-record aggregators indicate the entity was deregistered, so it does not appear to be an active operating company under this exact legal name as of the most recent available records.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Yuancheng Gongchuang Technology.